Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX01 in Rheumatoid Arthritis
NCT03522415Phase 3Completed
- Sponsor
- Henlius
- Start
- May 2018
- Primary completion
- Apr 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Henlius. Started May 2018; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03522415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522415.